AF
XENT

Amalgamated Financial’s Intersect ENT, Inc XENT Stock Holding History

Amalgamated Financial’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$152K Buy
+5,422
New +$149K ﹤0.01% 2003

Other funds holding XENT

VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amalgamated Financial's XENT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Intersect ENT, Inc (XENT) in Q1 2022: 5,422 shares worth $152K. The stake represents ﹤0.01% of the portfolio and ranks #2003 among its holdings.

131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

  • Amalgamated Financial held 5,422 shares of Intersect ENT, Inc worth $152K as of Q1 2022.
  • Intersect ENT, Inc was a new Amalgamated Financial position in Q1 2022.
  • Intersect ENT, Inc made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2003 holding.
  • 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.